ATE213268T1 - Fanconi-gen ii - Google Patents

Fanconi-gen ii

Info

Publication number
ATE213268T1
ATE213268T1 AT98921434T AT98921434T ATE213268T1 AT E213268 T1 ATE213268 T1 AT E213268T1 AT 98921434 T AT98921434 T AT 98921434T AT 98921434 T AT98921434 T AT 98921434T AT E213268 T1 ATE213268 T1 AT E213268T1
Authority
AT
Austria
Prior art keywords
fanconi
polypeptide
gen
antibody
nucleic acid
Prior art date
Application number
AT98921434T
Other languages
English (en)
Inventor
Manfred Kubbies
Andreas Machl
Simone Planitzer
Original Assignee
Roche Diagnostics Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roche Diagnostics Gmbh filed Critical Roche Diagnostics Gmbh
Priority claimed from PCT/EP1998/001994 external-priority patent/WO1998045428A1/de
Application granted granted Critical
Publication of ATE213268T1 publication Critical patent/ATE213268T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biotechnology (AREA)
  • Toxicology (AREA)
  • Hospice & Palliative Care (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Oncology (AREA)
  • Food Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Fats And Perfumes (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT98921434T 1997-04-07 1998-04-06 Fanconi-gen ii ATE213268T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP97105688 1997-04-07
PCT/EP1998/001994 WO1998045428A1 (de) 1997-04-07 1998-04-06 Fanconi-gen ii

Publications (1)

Publication Number Publication Date
ATE213268T1 true ATE213268T1 (de) 2002-02-15

Family

ID=8226668

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98921434T ATE213268T1 (de) 1997-04-07 1998-04-06 Fanconi-gen ii

Country Status (5)

Country Link
JP (1) JP2000510002A (de)
AT (1) ATE213268T1 (de)
AU (1) AU723543B2 (de)
CA (1) CA2285605A1 (de)
DE (1) DE59803082D1 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL2325306T3 (pl) 2005-02-25 2014-07-31 Oncotherapy Science Inc Szczepionki peptydowe do zastosowania w nowotworach płuc, wykazujących ekspresję polipeptydów TTK, URLC10 lub KOC1

Also Published As

Publication number Publication date
CA2285605A1 (en) 1998-10-15
JP2000510002A (ja) 2000-08-08
AU723543B2 (en) 2000-08-31
AU7429398A (en) 1998-10-30
DE59803082D1 (en) 2002-03-21

Similar Documents

Publication Publication Date Title
HUT77049A (hu) Katepszin-02-fehérjék, -nukleinsavak és -ellenanyagok
ATE348178T1 (de) Aktivierbare rekombinante neurotoxine
ATE454393T1 (de) Egvii-endoglucanase und dafür codierende nukleinsäuren
ATE490311T1 (de) Mutanten der alpha-amylase
DE69931507D1 (de) Interferon-beta fusionsproteine und deren verwendungen
DE69535829D1 (de) Verbesserung in bezug auf bindungsproteine bei der erkennung von dna
DE69534568D1 (de) Säugetier-telomerase
DE69435307D1 (de) Bazillus Thuringiensis und dessen insektizide Proteine
WO1996027665A3 (en) Neuron-restrictive silencer factor proteins
EP0763105A4 (de) Für ein fibroblasten-aktivierungsproteinkodierende nukleinsäure und verwendungen dafür
DE69736975D1 (de) Enzym mit galaktanaseaktivität
DE69634077D1 (de) Haemophilus adhäsionsproteinen
DE69838810D1 (de) Gen von alteromonas
DE59803082D1 (en) Fanconi-gen ii
ATE346087T1 (de) Hepatitis e-virus aus dem schwein und dessen verwendungen
AU1818399A (en) Novel flea epoxide hydrolase nucleic acid molecules, proteins and uses thereof
DK1005532T3 (da) Isolerede nukleinsyremolekyler kodende for SSX familiemedlemmer og anvendelser deraf
TW342413B (en) Novel toxins isolated from Bracon Hebetor
FR2703124B1 (fr) Soufflet elastiquement deformable.
DK1196607T3 (da) Antibakterielt chlamysin B-protein, gen kodende derfor samt ekspressionssystem
ATE361369T1 (de) Adenovirale systeme und deren anwendungen
SE0101519D0 (sv) Nucleic ACID
ITRM950434A0 (it) Polipeptide per la riparazione di informazione genetica, sequenza nucleotidica che codifica per esso e procedimento per la sua preparazione.
ATE307201T1 (de) Srcr domäne-enthaltendes protein
YU48719B (sh) Lizin so 6-hloro-5-fluoro-3-(2-tenoil)-2-oksindol-1-karboksamida

Legal Events

Date Code Title Description
REN Ceased due to non-payment of the annual fee